| Factor Information | |
|---|---|
| Data ID | 1511 |
| Factor | survivor with different NT pro-BNP |
| Description | N/A |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | predictive value of NT pro-BNP in CHD |
| p Value | <0.0001 |
| OR | 0.85 |
| Conclusion | The optimal discrimination value of NT-proBNP for the prediction of death was 630pg/ml. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 535 |
| CHD Type | isolated CHD |
| CHD Subtype | PA/ccTGA/VSD/NA/SV/ES/PAH/CoA/EA/TGA/TOF/ASD/AVSD/TA/PS/AVD |
| Reference | |
|---|---|
| PMID | 26404943 |
| Year | 2016 |
| Title | Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Adults With Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | blood | |
| Region | Czech, Prague | |
| Method | Mann-Whitney U-test and ROC analysis | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | survivor with NT pro-BNP<630pg/ml(Treatment) | survivor with NT pro-BNP≥630pg/ml(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.94 | 0.65 |
